LIGHT expression by mucosal T cells may regulate IFN-γ expression in the intestine

被引:40
作者
Cohavy, O
Zhou, J
Granger, SW
Ware, CF
Targan, SR
机构
[1] Cedars Sinai Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA
[2] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.173.1.251
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TNF superfamily of cytokines play an important role in T cell activation and inflammation. Sustained expression of lymphotoxin-like inducible protein that competes with glycoprotein D for binding herpesvirus entry mediator on T cells (LIGHT) (TNFSF14) causes a pathological intestinal inflammation when constitutively expressed by mouse T cells. In this study, we characterized LIGHT expression on activated human T cell subsets in vitro and demonstrated a direct proinflammatory effect on regulation of IFN-gamma. LIGHT was induced in memory CD45RO CD4(+) T cells and by IFN-gamma-producing CD4(+) T cells. Kinetic analysis indicated rapid induction of LIGHT by human lamina propria T cells, reaching maximal levels by 2-6 h, whereas peripheral blood or lymph node-derived T cells required 24 h. Further analysis of intestinal specimens from a 41 patient cohort by flow cytometry indicated membrane LIGHT induction to higher peak levels in lamina propria T cells from the small bowel or rectum but not colon, when compared with lymph node or peripheral blood. Independent stimulation of the LIGHT receptor, herpesvirus entry mediator, induced IFN-gamma production in lamina propria T cells, while blocking LIGHT inhibited CD2-dependent induction of IFN-gamma synthesis, indicating a role for LIGHT in the regulation of IFN-gamma and as a putative mediator of proinflammatory T-T interactions in the intestinal mucosa. Taken together, these findings suggest LIGHT-herpesvirus entry mediator mediated signaling as an important immune regulatory mechanism in mucosal inflammatory responses.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 52 条
  • [1] Regulation of immune responses of the intestinal mucosa
    AbreuMartin, MT
    Targan, SR
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 1996, 16 (03) : 277 - 309
  • [2] Aranda R, 1997, J IMMUNOL, V158, P3464
  • [3] Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease
    Bamias, G
    Martin, C
    Marini, M
    Hoang, S
    Mishina, M
    Ross, WG
    Sachedina, MA
    Friel, CM
    Mize, J
    Bickston, SJ
    Pizarro, TT
    Wei, P
    Cominelli, F
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (09) : 4868 - 4874
  • [4] BLASER MJ, 1984, GASTROENTEROLOGY, V87, P888
  • [5] Brandtzaeg P, 1998, CHEM IMMUNOL, V71, P1
  • [6] Browning JL, 1997, J IMMUNOL, V159, P3288
  • [7] Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology
    Brunner, T
    Wasem, C
    Torgler, R
    Cima, I
    Jakob, S
    Corazza, N
    [J]. SEMINARS IN IMMUNOLOGY, 2003, 15 (03) : 167 - 176
  • [8] CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease
    Cong, YZ
    Brandwein, SL
    McCabe, RP
    Lazenby, A
    Birkenmeier, EH
    Sundberg, JP
    Elson, CO
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) : 855 - 864
  • [9] NK cell and DC interactions
    Cooper, MA
    Fehniger, TA
    Fuchs, A
    Colonna, M
    Caligiuri, MA
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (01) : 47 - 52
  • [10] A METALLOPROTEASE INHIBITOR BLOCKS SHEDDING OF THE 80-KD TNF RECEPTOR AND TNF PROCESSING IN T-LYMPHOCYTES
    CROWE, PD
    WALTER, BN
    MOHLER, KM
    OTTENEVANS, C
    BLACK, RA
    WARE, CF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) : 1205 - 1210